 |
|
A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy
Tae-Kyu Jang, So-Jin Shin, Hyewon Chung, Sang-Hoon Kwon, Soon-Do Cha, Eunbi Lee, Changmin Shin, Chi-Heum Cho
Obstet Gynecol Sci. 2017;60(6):549-557. Published online 2017 Oct 17 DOI: https://doi.org/10.5468/ogs.2017.60.6.549
|
|
Citations to this article as recorded by
 Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
Yanna Ye, Zhiqiang Li, Shan Kang, Yongxiu Yang, Bin Ling, Li Wang, Jilong Yao, Pengfei Li, Xueqin Wang, Shipeng Gong, Huijian Fan, Yanxiang Kong, Yuye Cao, Jinghe Lang, Ping Liu, Chunlin Chen
BMC Cancer.2023;[Epub] CrossRef Calidad de vida en pacientes con diagnóstico de cáncer de cérvix en tratamiento con quimioterapia y radioterapia
Krisna Mishel Morales Chew, Erick Estuardo Estrada Zaldaña
Revista de la Facultad de Medicina.2023; 1(34): 50. CrossRef Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer
Ruo-nan Yan, Zhen Zeng, Fang Liu, Yuan-yuan Zeng, Tao He, Zhong-zheng Xiang, Bai-lu Zhang, Han-lin Gong, Lei Liu
Medicine.2020; 99(5): e18738. CrossRef
|